Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 4/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.34 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.34 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31035174 | 0.79 | AKT1 (0.35) | — | |
| SCHEMBL31035313 | 0.77 | KDM4E (0.36) | ESR1ESR2MAOBCSNK2A2CSNK2B | |
| SCHEMBL31035594 | 0.76 | ESR2 (0.39) | ESR1ESR2MAOBCSNK2A2CSNK2B | |
| SCHEMBL31035774 | 0.76 | AKT1 (0.37) | ESR1ESR2CDK2 | |
| SCHEMBL31035360 | 0.74 | ESR1 (0.37) | ESR1ESR2MAOBCSNK2A2CSNK2B | |
| SCHEMBL23886990 | 0.73 | ESR1 (0.36) | ESR1ESR2MAOBCSNK2A2CSNK2B | |
| SCHEMBL23887150 | 0.73 | ESR1 (0.36) | ESR1ESR2MAOBCSNK2A2CSNK2B | |
| SCHEMBL24912965 | 0.73 | ALDH1A1 (0.50) | ESR1ESR2MAOBCSNK2A2CSNK2B | |
| SCHEMBL3267026 | 0.72 | ESR2 (0.47) | ESR1ESR2MAOBCSNK2A2CSNK2B | |
| SCHEMBL23887133 | 0.72 | AKT1 (0.52) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680612-A1 | CHEMICAL COMPOUNDS | AN2 Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192309-A1 | CHEMICAL COMPOUNDS | REACTIVE BIOSCIENCES, INC. (US) | 2024-09-19 | — | — | WO | disclosed |